2-methoxyoestradiol inhibits glucose transport in rodent skeletal muscle: Experimental physiology

Experimental Physiology

Volumn 95, Issue 8, 2010, Pages 892-898

  Zhang, Shi Jin ^a   Sandström, Marie ^a   Ahlsén, Maria ^a   Ivarsson, Niklas ^a   Zhu, Hua ^b   Ma, Jianjie ^b   Ren, Jian Ming ^b   Westerblad, Håkan ^a   Katz, Abram ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; GLUCOSE TRANSPORTER 4; HYDROGEN PEROXIDE; INSULIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; 2-METHOXYOESTRADIOL; DEOXYGLUCOSE; ESTRADIOL; GLUCOSE;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME INHIBITION; ESTROGEN ACTIVITY; EXTENSOR DIGITORUM LONGUS MUSCLE; GLUCOSE TRANSPORT; HYPOXIA; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; ANALOGS AND DERIVATIVES; ANIMAL; ANOXIA; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ANOXIA; DEOXYGLUCOSE; ESTRADIOL; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYDROGEN PEROXIDE; INSULIN; MALE; MICE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; RATS;

EID: 77954551887     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.053405     Document Type: Article

References (29)

1. Afzal I, Cunningham P Naftalin RJ (2002). Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1. Biochem J 365, 707 719.
2. Basaria S, Muller DC, Carducci MA, Egan J Dobs AS (2006). Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106, 581 588.
3. Bryant NJ, Govers R James DE (2002). Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3, 267 277.
4. Cushman M, He HM, Katzenellenbogen JA, Lin CM Hamel E (1995). Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. J Med Chem 38, 2041 2049.
5. Das U (2002). A radical approach to cancer. Med Sci Monit 8, RA79 RA92.
6. D'Eon TM, Rogers NH, Stancheva ZS Greenberg AS (2008). Estradiol and the estradiol metabolite, 2-hydroxyestradiol, activate AMP-activated protein kinase in C2C12 myotubes. Obesity (Silver Spring) 16, 1284 1288.
7. Hammarsten J Hogstedt B (2005). Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41, 2887 2895.
8. Hardie DG Sakamoto K (2006). AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 21, 48 60.
9. Holloszy JO (2003). A forty-year memoir of research on the regulation of glucose transport into muscle. Am J Physiol Endocrinol Metab 284, E453 E467.
10. Huang P, Feng L, Oldham EA, Keating MJ Plunkett W (2000). Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407, 390 395.
11. Katz A (2007). Modulation of glucose transport in skeletal muscle by reactive oxygen species. J Appl Physiol 102, 1671 1676.
12. Lakhani NJ, Lepper ER, Sparreboom A, Dahut WL, Venitz J Figg WD (2005). Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 19, 1176 1182.
13. Li CH, Bai L, Li DD, Xia S Xu T (2004). Dynamic tracking and mobility analysis of single GLUT4 storage vesicle in live 3T3-L1 cells. Cell Res 14, 480 486.
14. Lin HL, Yang MH, Wu CW, Chen PM, Yang YP, Chu YR, Kao CL, Ku HH, Lo JF, Liou JP, Chi CW Chiou SH (2007). 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer. Int J Cancer 121, 2547 2555.
15. Mooberry SL (2003). Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 6, 355 361.
16. Robinson R, Robinson LJ, James DE Lawrence JC Jr. (1993). Glucose transport in L6 myoblasts overexpressing GLUT1 and GLUT4. J Biol Chem 268, 22119 22126.
17. Sandström ME, Zhang SJ, Silva JP, Reid MB, Westerblad H Katz A (2006). Role of reactive oxygen species in contraction-mediated glucose transport in skeletal muscle. J Physiol 575, 251 262.
18. Sandström ME, Zhang SJ, Westerblad H Katz A (2007). Mechanical load plays little role in contraction-mediated glucose transport in mouse skeletal muscle. J Physiol 579, 527 534.
19. Shang W, Konidari I Schomberg DW (2001). 2-Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. Biol Reprod 65, 622 627.
20. Shashkin PN, Koshkin A, Langley DR, Ren J-M, Westerblad H Katz A (1995). Effects of CGS 9343B (a putative calmodulin antagonist) on isolated skeletal muscle: dissociation of signaling pathways for insulin-mediated activation of glycogen synthase and hexose transport. J Biol Chem 270, 25613 25618.
21. Shim H, Chun YS, Lewis BC Dang CV (1998). A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci U S A 95, 1511 1516.
22. Singh A, Purohit A, Hejaz HA, Potter BV Reed MJ (2000). Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate. Mol Cell Endocrinol 160, 61 66.
23. Smith MR, Lee H Nathan DM (2006). Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab 91, 1305 1308.
24. Sutherland TE, Anderson RL, Hughes RA, Altmann E, Schuliga M, Ziogas J Stewart AG (2007). 2-Methoxyestradiol - a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents. Drug Discov Today 12, 577 584.
25. Sweeney C, Liu G, Yiannoutsos C, Kolesar J, Horvath D, Staab MJ, Fife K, Armstrong V, Treston A, Sidor C Wilding G (2005). A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Clin Cancer Res 11, 6625 6633.
26. Tagg SL, Foster PA, Leese MP, Potter BV, Reed MJ, Purohit A Newman SP (2008). 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-d-glucose in combination: a potential treatment for breast and prostate cancer. Br J Cancer 99, 1842 1848.
27. Tevaarwerk AJ, Holen KD, Alberti DB, Sidor C, Arnott J, Quon C, Wilding G Liu G (2009). Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies. Clin Cancer Res 15, 1460 1465.
28. Zhang SJ, Sandstrom ME, Aydin J, Westerblad H, Wieringa B Katz A (2008). Activation of glucose transport and AMP-activated protein kinase during muscle contraction in adenylate kinase-1 knockout mice. Acta Physiol (Oxf) 192, 413 420.
29. Zhang X, Jia Y, Jackson EK Tofovic SP (2007). 2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats. J Cardiovasc Pharmacol 49, 56 63.